5 Einträge gefunden

1. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials

   1. van Mackelenbergh, Marion T
   2. Denkert, Carsten
   3. Nekljudova, Valentina
   4. Karn, Thomas
   5. Schem, Christian
   6. Marmé, Frederik
   7. Stickeler, Elmar

   2018 - Forschungsinformationssystem des UKE
2. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment

   1. Bauer, Emanuel C A
   2. Schochter, Fabienne
   3. Widschwendter, Peter
   4. DeGregorio, Amelie
   5. Andergassen, Ulrich
   6. Friedl, Thomas W P
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
3. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

   1. Stevic, Ines
   2. Müller, Volkmar
   3. Weber, Karsten
   4. Fasching, Peter A
   5. Karn, Thomas
   6. Marmé, Frederic
   7. Schem, Christian

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
4. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Fehm, Tanja
   3. Janni, Wolfgang
   4. Aktas, Bahriye
   5. Fasching, Peter A
   6. Kasimir-Bauer, Sabine
   7. Milde-Langosch, Karin

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
5. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Pantel, Klaus
   5. Rack, Brigitte
   6. Janni, Wolfgang
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE